Free Trial

Tilray Brands (NASDAQ:TLRY) Shares Down 2.6% - What's Next?

Tilray Brands logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Tilray Brands shares fell 2.6% in Tuesday trading, closing near $4.88 after a session that saw lighter-than-average volume. The stock remains well below its 50-day and 200-day moving averages, underscoring continued weakness.
  • Recent company news was mixed but included some positives: Tilray’s beverage brands launched summer soccer promotions and Breckenridge Distillery introduced a limited-edition bourbon tied to America’s 250th anniversary. These efforts could help boost brand visibility and near-term sales.
  • Analyst sentiment remains cautious overall, with a consensus Hold rating and an average price target of $11.50. Tilray also missed quarterly EPS expectations in its latest earnings report, adding to concerns about profitability.
  • Interested in Tilray Brands? Here are five stocks we like better.

Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) traded down 2.6% during mid-day trading on Tuesday . The company traded as low as $4.85 and last traded at $4.88. 3,505,275 shares traded hands during trading, a decline of 19% from the average session volume of 4,334,543 shares. The stock had previously closed at $5.01.

Key Headlines Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

  • Positive Sentiment: Tilray’s beverage brands rolled out multiple summer soccer promotions across the U.S. and Canada, including watch parties, fan events, limited-edition packaging, sweepstakes, and match-day specials for Breckenridge Brewery, BrewDog USA, 10 Barrel Brewing, Pub Beer, and Shock Top. These campaigns could support brand visibility and near-term sales during a major global sporting event. Article Title
  • Positive Sentiment: Breckenridge Distillery introduced Patriotic Reserve Bourbon Whiskey, a limited-release product tied to America’s 250th anniversary and Independence Day themes, giving Tilray another brand-led revenue opportunity and marketing angle. Article Title
  • Neutral Sentiment: A recent weekly cannabis-sector roundup mentioned Tilray Medical’s launch of a first German-grown premium cannabis brand, but the article also highlighted mixed performance across the sector, making the overall stock impact unclear. Article Title
  • Negative Sentiment: Investor commentary published on June 15 argued that Tilray’s stock remains weak and could go lower, reinforcing concerns about the company’s longer-term share price trend and profitability. Article Title

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Roth Mkm upgraded Tilray Brands from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research report on Thursday, April 2nd. TD Cowen lowered their price target on Tilray Brands from $10.00 to $7.00 and set a "buy" rating on the stock in a research report on Monday, March 30th. Wall Street Zen upgraded Tilray Brands from a "sell" rating to a "hold" rating in a research report on Saturday, March 21st. ATB Cormark Capital Markets lowered their price target on Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating on the stock in a research report on Thursday, April 2nd. Finally, Weiss Ratings downgraded Tilray Brands from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, May 13th. Three analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $11.50.

Read Our Latest Stock Report on TLRY

Tilray Brands Price Performance

The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66. The stock has a 50 day moving average price of $5.91 and a 200-day moving average price of $7.46. The stock has a market capitalization of $569.93 million, a price-to-earnings ratio of -0.36 and a beta of 1.88.

Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.10). The firm had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. Tilray Brands had a negative return on equity of 3.31% and a negative net margin of 156.51%.During the same period in the prior year, the firm earned ($0.87) earnings per share. On average, analysts forecast that Tilray Brands, Inc. will post -0.58 earnings per share for the current year.

Insiders Place Their Bets

In other Tilray Brands news, Director David G. Hopkinson sold 33,556 shares of the business's stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total transaction of $232,878.64. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.84% of the company's stock.

Hedge Funds Weigh In On Tilray Brands

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Essential Partners LLC boosted its stake in Tilray Brands by 110,137.5% during the first quarter. Essential Partners LLC now owns 8,819 shares of the company's stock worth $57,000 after buying an additional 8,811 shares during the last quarter. Entropy Technologies LP acquired a new position in Tilray Brands during the first quarter worth $123,000. Baader Bank Aktiengesellschaft raised its position in Tilray Brands by 17.7% in the first quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company's stock valued at $293,000 after purchasing an additional 7,226 shares during the period. Dimensional Fund Advisors LP raised its position in Tilray Brands by 82.9% in the first quarter. Dimensional Fund Advisors LP now owns 87,803 shares of the company's stock valued at $568,000 after purchasing an additional 39,801 shares during the period. Finally, Swiss National Bank raised its position in Tilray Brands by 4.1% in the first quarter. Swiss National Bank now owns 230,503 shares of the company's stock valued at $1,491,000 after purchasing an additional 9,100 shares during the period. Institutional investors and hedge funds own 9.35% of the company's stock.

About Tilray Brands

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines